August 7th 2025
New findings confirm TearCare's long-term effectiveness for dry eye disease, showing significant patient improvements with minimal treatments over 2 years.
August 4th 2025
TearCare is associated with greater health utility over time but also resulted in significant cost savings compared with CsA
The solution was approved by the US Food and Drug Administration in late May 2025.
RTP-008 features sustained immunosuppressant delivery for long-term therapeutic effects.
July 17th 2025
A Prescription Drug User Fee Act (PDUFA) target action date of December 16, 2025, was assigned by the FDA.
Cyclosporine Formulation Challenges
Watch
Initiating Anti-Inflammatory/Immunomodulatory Therapy
Glaucoma Medications and Dry Eye Disease
Impact of Dry Eye on Surgical Outcome; Patient Screening
Dry Eye Disease Epidemiology
Patient Counseling on Generic vs. Branded
Cost and Substitution Issues
Generic vs. Branded Ophthalmic Medications
Myths and misconceptions about autologous serum for dry eye
Read More
ASCRS 2020: Clinical trial results of KP1-121 0.25% for dry eye treatment
ASCRS 2020: Evaluation of intraoperative use of DEXYCU on signs/symptoms of dry eye
Investigational topical corticosteroid demonstrates efficacy for dry eye
Caring for dry eye patients through the coronavirus pandemic
Dry eye cases increase in patients with sleep apnea
Trifocal IOL a key for premium cataract surgery practice
Addressing MGD with thermal pulsation system
The use of a thermal lid pulsation device can prove to be an important component of routine practice for the treatment of the signs and symptoms of meibomian gland dysfunction.
It takes a village to care for dry eye patients
Lab tear tests aid reimbursements, clinical application of dry eye
New techniques probed for managing dry eye disease
Pulsing or probing for MGD: How current devices compare
Effect of vaping on the eyes
Surfing the dry eye pipeline
How to implement IPL into your practice
Everything you thought you knew about astigmatism and dry eye is wrong
3 questions patients always ask about thermal pulsation therapy
Using IPL to treat glaucoma patients with dry eye disease
Innovations focusing on improved patient experience
Treating dry eye with recombinant human nerve growth factor
A new therapy is being investigated in a phase IIb trial to test its safety and effectiveness in patients with moderate-to-severe dry eye disease.